Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ticagrelor vs Clopidogrel Post-PCI: TADCLOT Results
Added: 1 week ago Source:  Radcliffe Cardiology
The first month following primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is a period of high risk for major adverse cardiovascular events (MACEs). The TADCLOT trial aimed to compare the efficacy of ticagrelor against a twice-daily clopidogrel regimen in this critical short-term window.¹The TADCLOT (Twice-A-Day CLOpidogrel vs Ticagrelor)… View more

Anticoagulation

Intervention
ACC 25: The SMART-CHOICE 3 Trial
Author(s): Joo-Yong Hahn Added: 8 months ago
ACC 25 - SMART-CHOICE 3 Trial finds clopidogrel monotherapy to be the optimal anti-thrombotic strategy in high risk patients with contemporary drug-eluting stents.Dr Joo-Yong Hahn (Samsung Medical Center, Seoul, KR) joins us onsite at ACC Conference 2025 to discuss the findings from the SMART-CHOICE 3 study (NCT04418479). The study aims to evaluate the efficacy and safety of clopidogrel… View more

Anticoagulation

Intervention
Individualising Antithrombotic Strategies for ACS and CCS
Author(s): Robert F Storey Added: 1 year ago

Anticoagulation

Intervention
Research Area(s) / Expertise: Job title: Professor
Professor Keith AA Fox is Duke of Edinburgh Professor of Cardiology at the University of Edinburgh. Previous posts included Assistant Professor of Internal Medicine and Cardiology at Washington University School of Medicine, St Louis, USA; Senior Lecturer in Cardiology and Honorary Consultant Cardiologist at the University of Wales College of Medicine, Cardiff; Head of Division of Medical and… View more
View from the Thoraxcenter: What's Hot at ACC.25?
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 9 months ago
Join renowned interventional cardiologists Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) for an exclusive preview of ACC.25's most significant late-breaking science.This episode of View from the Thoraxcenter delivers authoritative analysis of pivotal cardiovascular trials set to revolutionize clinical practice and research. Elevate your conference… View more

Heart Failure

Intervention
Shortened Dual Antiplatelet Therapy
Author(s): Kevin S Tang , Shoujit Banerjee , George Tang , et al Added: 2 years ago

Anticoagulation

Intervention
ESC 23: The STOPDAPT-3 Study
Author(s): Masahiro Natsuaki Added: 2 years ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111). In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at… View more

Intervention

MI/ACS
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 1 year ago

Anticoagulation

Intervention
ACC 2025 Late-Breaking and Featured Science Collection
Author(s): Rajesh Kharbanda , Harriette Van Spall Added: 9 months ago
Keep up-to-date with our video collection on the American College of Cardiology's 74th annual congress, covering late-breaking science, featured science and clinical horizon sessions. Don't miss the preview and wrap-up of the congress in our View From the Thoraxcenter series, concise Expert Interviews with select faculty offering take-home messages for practice, and our Highlights summarising the… View more

Heart Failure

Intervention
Superior Mesenteric Artery Occlusion Following COVID-19 Pneumonia
Author(s): Duy Cao Phuong Le , Hoa The Bui , Quan Duy Vo Added: 1 year ago

COVID-19

Intervention